National Penn Investors Trust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-3,039
Closed -$256K 228
2015
Q4
$256K Sell
3,039
-300
-9% -$24.9K 0.03% 187
2015
Q3
$279K Hold
3,339
0.03% 176
2015
Q2
$279K Hold
3,339
0.03% 186
2015
Q1
$243K Sell
3,339
-1,600
-32% -$114K 0.03% 196
2014
Q4
$341K Hold
4,939
0.04% 141
2014
Q3
$320K Buy
4,939
+1,600
+48% +$101K 0.04% 146
2014
Q2
$208K Buy
+3,339
New +$199K 0.02% 174

Other funds holding LLY

National Penn Investors Trust's LLY Position: Q1 2016 in Review

National Penn Investors Trust sold out of Eli Lilly (LLY) in Q1 2016, closing a stake of 3,039 shares — an estimated $256K sold.

National Penn Investors Trust first reported a position in LLY in Q2 2014 and held it in 7 quarters. The position peaked at $341K in Q4 2014. 1,152 funds tracked by Wall St. Rank hold LLY as of Q1 2016.

  • National Penn Investors Trust reported no remaining Eli Lilly position as of Q1 2016 after selling out during the quarter.
  • National Penn Investors Trust sold 3,039 Eli Lilly shares in Q1 2016, an estimated $256K.
  • National Penn Investors Trust first reported a position in Eli Lilly in Q2 2014 and held it in 7 quarters.
  • National Penn Investors Trust's Eli Lilly position peaked at $341K in Q4 2014.
  • 1,152 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2016.

Based on National Penn Investors Trust's 13F filing for Q1 2016, filed 11 May 2016.